These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5894386)

  • 1. [The neutralizing antibody in serum, 2 years after infection with Coxsackie B5 and A9 viruses].
    Nakao T; Hinuma Y
    Nihon Shonika Gakkai Zasshi; 1965 Jul; 69(7):640-2. PubMed ID: 5894386
    [No Abstract]   [Full Text] [Related]  

  • 2. Coxsackie virus infection in association with heart affection in man.
    Petrovicová A; Cervenka J; Egnerová A
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):251-7. PubMed ID: 2824602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Coxsackie virus infection in patients with dilated cardiomyopathy.
    Riecanský I; Schreinerová Z; Egnerová A; Petrovicová A; Bzduchová O
    Cor Vasa; 1989; 31(3):225-30. PubMed ID: 2788555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistance of neutralizing antibody to Coxsackievirus B5 following aseptic meningitis.
    Hinuma Y; Nakao T
    Jpn J Med Sci Biol; 1965 Jun; 18(3):157-60. PubMed ID: 5294928
    [No Abstract]   [Full Text] [Related]  

  • 5. Mercaptoethanol-sensitive neutralizing-antibody in natural infection with coxsackievirus B5.
    Ohta-Hatano R; Hinuma Y
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):725-9. PubMed ID: 5918940
    [No Abstract]   [Full Text] [Related]  

  • 6. Mumps or Coxsackie A9 virus antibody in the cerebrospinal fluid of patients with meningitis or encephalitis.
    Connolly JH; Robinson FL; Canavan DA
    Ir J Med Sci; 1975 Feb; 144(2):61-6. PubMed ID: 1112672
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac manifestations during a Coxsackie B5 epidemic.
    Helin M; Savola J; Lapinleimu K
    Br Med J; 1968 Jul; 3(5610):97-9. PubMed ID: 5662968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Presence of neutralizing antibodies against Coxsackie virus and Echoviruses 9,11 and 12 in subjects of Accra (Ghana)].
    Russo V; D'Arrigo C; Rosei L
    Arch Ital Sci Med Trop Parassitol; 1968; 49(5):145-52. PubMed ID: 5715929
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic and epidemiological features of a coxsackie virus epidemic in newborn infants (author's transl)].
    Hofmann H; Sacher M
    Wien Klin Wochenschr; 1979 Jun; 91(13):451-5. PubMed ID: 463044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formation and persistence of latexagglutination-inhibiting antibodies in rhesus monkeys infected with Coxsackie virus type B4 (author's transl)].
    Brade H; Klein M; Schmidt WA
    Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):461-5. PubMed ID: 822619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coxsackie viruses in Rumania. II. Immuno-serological studies].
    Arion R; Buimovici-Klein E; Slobodă E; Dinculescu M
    Stud Cercet Inframicrobiol; 1968; 19(5):333-42. PubMed ID: 5718078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heart disorder due to Coxsackie viruses B].
    Moravcová J; Ledec J; Kopecká D
    Vnitr Lek; 1973 Jul; 19(7):660-5. PubMed ID: 4726016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity response of 3 animal species (guinea pigs, hamsters, mice) to various Coxsackie viruses of group A. II. Study of antibodies detected by gel immunodiffusion: comparison with complement fixing antibodies].
    Bringuier JP; Gaudin OG; Brigaud M; Terraillon J; Sohier R
    Ann Inst Pasteur (Paris); 1971 Oct; 121(4):551-61. PubMed ID: 5004043
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological response of the newborn infant to Coxsackie B-4 infection.
    Sieber OF; Kilgus AH; Fulginiti VA; Pearlman D
    Pediatrics; 1967 Sep; 40(3):444-6. PubMed ID: 6036193
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research, in a sample of the population of Asmara (Eritrea), on antibodies neutralizing some types of enterovirus (poliovirus 1, 2 and 3; Coxsackie virus B 1 to B 5; ECHO virus 9, 11, and 12)].
    Sebastiani A; Taglieri G; Balestrieri A
    Acta Med Ital Med Trop Subtrop Gastroenterol; 1965; 20(4):29-33. PubMed ID: 5181044
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus].
    Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O
    Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observations on a case of coxsackie B2 virus infection with an unusual immune response].
    Pierangeli L; Ravetta M; Vellucci A
    Boll Soc Ital Biol Sper; 1964 Mar; 40(6):242-3. PubMed ID: 5877106
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute pericarditis--an outbreak due to Coxsackie viruses B.
    Kirk ED; Marymont JH; Crow EW; Hayes WL; Rowan DF
    J Kans Med Soc; 1971 Feb; 72(2):47-53. PubMed ID: 5111444
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of the Coxsackie B virus complement fixation test (author's transl)].
    Hofmann H
    Wien Klin Wochenschr; 1975 Dec; 87(24):819-22. PubMed ID: 1226771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies in gamma-globulin preparations (author's transl)].
    Kunz Ch; Hofmann H; Stary A
    Wien Klin Wochenschr; 1977 Mar; 89(6):203-6. PubMed ID: 66804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.